PP 1.22 – 00120 Suppression of CD4+ T-cell-intrinsic immunity by HIV-1 latency-reversing HDACi

• J. Kazmierski,
• D. Postmus,
• E. Wyler,
• C. Fischer,
• K. Meixenberger,
• L. Loyal,
• A. Thiel,
• N. Bannert,
• M. Landthaler,
• C. Goffinet

Affiliations

J. Kazmierski

Institute of Virology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Berlin Institute of Health (BIH), Berlin, Germany

D. Postmus

Institute of Virology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Berlin Institute of Health (BIH), Berlin, Germany

E. Wyler

Berlin Institute for Medical Systems Biology, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany

C. Fischer

Scientific Genomics Platforms, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany

K. Meixenberger

Division of sexually transmitted bacterial pathogens and HIV, Robert Koch Institute, Berlin, Germany

L. Loyal

Si-M/“Der Simulierte Mensch” a Science Framework of Technische Universität Berlin and Charité – Universitätsmedizin Berlin, Berlin, Germany

A. Thiel

Si-M/“Der Simulierte Mensch” a Science Framework of Technische Universität Berlin and Charité – Universitätsmedizin Berlin, Berlin, Germany

N. Bannert

Division of sexually transmitted bacterial pathogens and HIV, Robert Koch Institute, Berlin, Germany

M. Landthaler

Berlin Institute for Medical Systems Biology, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany; IRI Life Sciences, Institute for Biology, Humboldt-Universität zu Berlin, Berlin, Germany

C. Goffinet

Institute of Virology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Berlin Institute of Health (BIH), Berlin, Germany